SPX3,763.49-19.79 -0.52%
DIA301.08-1.71 -0.56%
IXIC11,113.30-35.34 -0.32%

Cellectar Biosciences Granted U.S. Patent #11,439,709 Phospholipid Ether Analogs as Cancer-targeting Drug Vehicles

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6652&f=G&l=50&d=PTXT&p=134&S1=20220913&OS=20220913&RS=20220913

Benzinga · 09/13/2022 09:36
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6652&f=G&l=50&d=PTXT&p=134&S1=20220913&OS=20220913&RS=20220913